Cargando…

Editorial: Next generation γδ T cell-based tumor immunotherapy

Detalles Bibliográficos
Autores principales:	Tan, Andy Hee-Meng, Cheung, Alice Man Sze, Kabelitz, Dieter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9562770/ https://www.ncbi.nlm.nih.gov/pubmed/36248869 http://dx.doi.org/10.3389/fimmu.2022.1041362

Ejemplares similares

Editorial: γδ T Cells in Cancer
por: Coffelt, Seth B., et al.
Publicado: (2020)

Monitoring Circulating γδ T Cells in Cancer Patients to Optimize γδ T Cell-Based Immunotherapy
por: Oberg, Hans-Heinrich, et al.
Publicado: (2014)

Current Advances in γδ T Cell-Based Tumor Immunotherapy
por: Lo Presti, Elena, et al.
Publicado: (2017)

Cancer immunotherapy with γδ T cells: many paths ahead of us
por: Kabelitz, Dieter, et al.
Publicado: (2020)

Correction to: Cancer immunotherapy with γδ T cells: many paths ahead of us
por: Kabelitz, Dieter, et al.
Publicado: (2020)

γδ T cells: origin and fate, subsets, diseases and immunotherapy
por: Hu, Yi, et al.
Publicado: (2023)

Galectin-3 Released by Pancreatic Ductal Adenocarcinoma Suppresses γδ T Cell Proliferation but Not Their Cytotoxicity
por: Gonnermann, Daniel, et al.
Publicado: (2020)

TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells
por: Tawfik, Doaa, et al.
Publicado: (2019)

Revolution of CAR Engineering For Next-Generation Immunotherapy In Solid Tumors
por: Yu, Tao, et al.
Publicado: (2022)

Potential Use of γδ T Cell-Based Vaccines in Cancer Immunotherapy
por: Khan, Mohd Wajid A., et al.
Publicado: (2014)

γδ T cells in immunotherapies for B-cell malignancies
por: Rimailho, Léa, et al.
Publicado: (2023)

Human γδ T lymphocytes for immunotherapeutic strategies against cancer
por: Kabelitz, Dieter
Publicado: (2010)

Unleashing Natural Killer Cells in the Tumor Microenvironment–The Next Generation of Immunotherapy?
por: Ben-Shmuel, Aviad, et al.
Publicado: (2020)

Targeting Cytokine Signals to Enhance γδT Cell-Based Cancer Immunotherapy
por: Song, Yuan, et al.
Publicado: (2022)

Cancer Immunotherapy Using γδT Cells: Dealing with Diversity
por: Scheper, Wouter, et al.
Publicado: (2014)

γδ T Cells for Leukemia Immunotherapy: New and Expanding Trends
por: Barros, Mateus de Souza, et al.
Publicado: (2021)

A close look at current γδ T-cell immunotherapy
por: Ma, Ling, et al.
Publicado: (2023)

Gamma Delta T Cells (γδ T Cells) in Health and Disease: In Memory of Professor Wendy Havran
por: Kabelitz, Dieter
Publicado: (2020)

Editorial: “Recent Advances in Gamma/Delta T Cell Biology: New Ligands, New Functions, and New Translational Perspectives”
por: Kabelitz, Dieter, et al.
Publicado: (2015)

Immunosurveillance by human γδ T lymphocytes: the emerging role of butyrophilins
por: Kabelitz, Dieter, et al.
Publicado: (2017)

Reply to: Vitamin C as a promoter of γδ T cells
por: Kouakanou, Léonce, et al.
Publicado: (2021)

Next Generation Natural Killer Cells for Cancer Immunotherapy
por: Rossi, Fiorella, et al.
Publicado: (2022)

Immunotherapy With Human Gamma Delta T Cells—Synergistic Potential of Epigenetic Drugs?
por: Bhat, Jaydeep, et al.
Publicado: (2018)

Next Generation CD40 Agonistic Antibodies for Cancer Immunotherapy
por: Salomon, Ran, et al.
Publicado: (2022)

Editorial: Advanced Immunization Technologies for Next Generation Vaccines
por: Medaglini, Donata, et al.
Publicado: (2020)

The Vγ4/butyrophilin conspiracy: novel role of intraepithelial γδ T cells in chronic inflammatory bowel disease
por: Kabelitz, Dieter
Publicado: (2023)

Editorial: Extracellular vesicles in cancer immunosurveillance
por: Moloudizargari, Milad, et al.
Publicado: (2022)

Aiming for the Sweet Spot: Glyco-Immune Checkpoints and γδ T Cells in Targeted Immunotherapy
por: Bartish, Margarita, et al.
Publicado: (2020)

Tribody [(HER2)(2)xCD16] Is More Effective Than Trastuzumab in Enhancing γδ T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells
por: Oberg, Hans H., et al.
Publicado: (2018)

Vitamin C, From Supplement to Treatment: A Re-Emerging Adjunct for Cancer Immunotherapy?
por: Kouakanou, Léonce, et al.
Publicado: (2021)

Vitamin C and Vitamin D—friends or foes in modulating γδ T-cell differentiation?
por: Peters, Christian, et al.
Publicado: (2022)

Editorial: Dendritic Cell-Based Immunotherapy in Solid and Haematologic Tumors
por: Dolcetti, Riccardo, et al.
Publicado: (2020)

γδ T Cells and Tumor Microenvironment: From Immunosurveillance to Tumor Evasion
por: Lo Presti, Elena, et al.
Publicado: (2018)

Spleen tyrosine kinase mediates the γδTCR signaling required for γδT cell commitment and γδT17 differentiation
por: Muro, Ryunosuke, et al.
Publicado: (2023)

Plasticity of γδ T Cells: Impact on the Anti-Tumor Response
por: Lafont, Virginie, et al.
Publicado: (2014)

Phenotype and regulation of immunosuppressive Vδ2-expressing γδ T cells
por: Peters, Christian, et al.
Publicado: (2013)

The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting
por: Li, Yang, et al.
Publicado: (2021)

Activation of Human γδ T Cells: Modulation by Toll-Like Receptor 8 Ligands and Role of Monocytes
por: Serrano, Ruben, et al.
Publicado: (2020)

Editorial: Next generation B cell targeting therapies in autoimmune diseases
por: Li, Rui, et al.
Publicado: (2023)

Next-Generation Sequencing Analysis of the Human TCRγδ+ T-Cell Repertoire Reveals Shifts in Vγ- and Vδ-Usage in Memory Populations upon Aging
por: Kallemeijn, Martine J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ihit41vh79bgqd8p4j2u33c1od